OTC: LBTSF - Almirall, S.A.

Rentabilidad a seis meses: -3.54%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción Almirall, S.A.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa Almirall, S.A.

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally.

más detalles
The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.11
Дивиденд ао 0.1873
Сайт https://www.almirall.com
Цена ао 9.51
Cambio de precio por día: 0% (9.173)
Cambio de precio por semana.: 0% (9.173)
Cambio de precio por mes: 0% (9.173)
Cambio de precio en 3 meses.: -3.54% (9.51)
Cambio de precio en seis meses: -3.54% (9.51)
Cambio de precio por año: +0.8022% (9.1)
Cambio de precio en 3 años.: 0% (9.173)
Cambio de precio en 5 años.: 0% (9.173)
Cambio de precio en 10 años.: 0% (9.173)
Cambio de precio desde principios de año.: 0% (9.173)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 1.81 8
P/BV 1.23 9
P/E 384.08 1
EV/EBITDA 9.79 8
Total: 5.88

Eficiencia

Nombre Significado Calificación
ROA, % -1.79 0
ROE, % -2.91 0
Total: 1.17

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0.7143 7.14
Total: 3.25

Deber

Nombre Significado Calificación
Debt/EBITDA 1.98 7
Total: 9.4

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 13.53 2
Rentabilidad Ebitda, % -56.04 0
Rentabilidad EPS, % -137.83 0
Total: 0.4
Más detalles

Instituciones Volumen Compartir, %
Hartford International Value Fund 1491055 0.82
Vanguard International Stock Index-Total Intl Stock Indx 1169408 0.64
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 675345 0.37
Vanguard Whitehall Fds-Vanguard Advice Select Global Value Fd 665229 0.37
DFA Continental Small Company Series 461737 0.25
iShares Core MSCI EAFE ETF 448261 0.25
Old Westbury Small & Mid Cap Strategies Fund 328618 0.18
iShares MSCI EAFE Small Cap ETF 311168 0.17
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 290960 0.16
DFA International Core Equity Portfolio 263398 0.15



Supervisor Título profesional Pago año de nacimiento
Mr. Carlos Gallardo Piqué CEO, President, Member of Management Board & Chairman of the Board 53.55k 1972 (53 año)
Mr. Michael McClellan CFO & Member of Management Board N/A 1972 (53 año)
Mr. Eloi Crespo Cervera Chief Industrial Operations Officer & Member of Management Board N/A
Mr. Esteve Conesa Panicot Chief People & Culture Officer and Member of Management Board N/A
Dr. Volker Koscielny Chief Medical Officer & Member of Management Board N/A
Dr. Karl Ziegelbauer Chief Scientific Officer & Member of Management Board N/A
Mr. Paolo Cionini Chief Commercial Officer Europe & International and Member of Management Board N/A
Ms. Isabel Cristina Gomes Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board N/A
Ms. Mercedes Diz Lopez Chief Marketing Officer & Member of Management Board N/A
Mr. Pablo Divasson del Fraile Senior Director of Investor Relations N/A

DIRECCIÓN: Spain, Barcelona, Ronda General Mitre. 151 - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.almirall.com